Curetis Submits Unyvero System, Respiratory Infection Panel for FDA Approval | GenomeWeb

NEW YORK (GenomeWeb) – German molecular diagnostics firm Curetis announced today that it has submitted its Unyvero system and Unyvero lower respiratory tract (LRT) panel for approval to the US Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.